Comparative Effects of Exercises on Pain, Cervical Proprioception Neck Disability and Visual Performance in Patients With Computer Vision Syndrome

November 11, 2026 updated by: Maria Mustafa, University of Management and Technology Lahore

Comparative Effects of Cervical Sensorimotor and Oculomotor Trainings on Pain, Cervical Proprioception, Neck Disability and Visual Performance in Patients With Computer Vision Syndrome

This study aims to compare the effectiveness of cervical sensorimotor training and oculomotor training in patients with Computer Vision Syndrome (CVS). It will evaluate their effects on neck pain, cervical proprioception, neck disability, and visual performance. Both interventions aim to improve cervical neuromuscular control and visual function through targeted exercises. The findings will help identify the more effective rehabilitation approach for managing musculoskeletal and visual symptoms associated with CVS.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 18-40 years.

    • Both genders.
    • Individuals using digital screens for more than 4 hours/day.
    • NPRS range between 4-6.
    • Presence of neck pain for at least 3 months
    • CVS-Q smart score 7-10.

Exclusion Criteria:

  • History of cervical trauma or surgery.
  • Vestibular disorders.
  • Neurological disorders.
  • Cervical radiculopathy/myelopathy.
  • Diagnosed migraine disorders.
  • visual impairment corrected by lenses/glasses
  • Inflammatory cervical conditions.
  • Recent physiotherapy treatment within last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cervical Sensorimotor Training

Participants will perform Neutral Return, Target Angles, and Movement Sequence exercises using laser-guided head movements, starting with 5 repetitions per movement and progressing according to tolerance. Sessions will last 30-40 minutes, 3 times per week for 8 weeks.

Participants will perform Neutral Return, Target Angles, and Movement Sequence exercises using laser-guided head movements, starting with 5 repetitions per movement and progressing according to tolerance. Sessions will last 30-40 minutes, 3 times per week for 6 weeks.

Active Comparator: Oculomotor Training

Group B will receive saccadic eye movements, smooth pursuit, and gaze stabilization exercises (X1 and X2), starting at 3 minutes per exercise with weekly progression. Sessions will last 30-40 minutes, 3 times per week for 8 weeks

Group B will receive saccadic eye movements, smooth pursuit, and gaze stabilization exercises (X1 and X2), starting at 3 minutes per exercise with weekly progression. Sessions will last 30-40 minutes, 3 times per week for 6 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale
Time Frame: Baseline and 6 weeks post treatment

Numeric Rating Scale is most frequently used instruments to measure pain intensity .The 11 point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs).

Baseline and 6 weeks post treatment
Neck Disability Index
Time Frame: Baseline and 6 weeks post treatment

Neck related disability will be assessed using the Neck Disability Index , a self-reported questionnaire consisting of 10 items that evaluate the impact of neck pain on daily activities, including personal care, work, and recreation. Each item is scored from 0 to 5, with a minimum total score of 0 and a maximum total score of 50. Scores of 0-4 indicate no disability, 5-14 indicate mild disability, 15-24 indicate moderate disability, 25-34 indicate severe disability, and 35-50 indicate complete disability. Higher scores indicate greater neck-related disability and a worse outcome, whereas lower scores indicate less disability and a better outcome.

Baseline and 6 weeks post treatment
Cervical Joint Position Error Test
Time Frame: Baseline and 6 weeks post treatment

This test measures neck proprioception (body awareness). A laser pointer on the head tracks how close someone can return to their starting position after moving their head with eyes closed. The closer they get, the better their proprioception. A difference over 4.5° suggests impaired awareness. The JPE test is dependable for checking neck movement sense

Baseline and 6 weeks post treatment
Visual Complaint Index
Time Frame: Baseline and 6 weeks post treatment

This is a questionnaire that asks about vision problems like eye strain, blurred or double vision, headaches, sensitivity to light, and fatigue especially from screen use or neck problems. Each symptom is rated for how bad and how often it is. Multiply those scores for each symptom and add them up for a total. Higher totals mean more symptoms. The Visual Complaint Index helps spot issues linked to Computer Vision Syndrome and neck-related visual problems

Baseline and 6 weeks post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 20, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 17, 2026

First Submitted That Met QC Criteria

October 17, 2026

First Posted (Actual)

October 23, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

6 months after the publication of manuscript

IPD Sharing Access Criteria

data can be requested from corresponding author

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe